You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
熱點掃描 | 生物技術板塊早盤拉昇
uSMART盈立智投1月10日消息,截止發稿,港股三大指數齊漲,恆生指數上漲0.76%,報23670.93點,成交額521.12億;恆生科技指上漲2.13%,報5620.55點,成交額106.08億;紅籌指數上漲0.79%報4059.92點,成交額24.55億。
生物技術板塊早盤開盤後大幅度拉漲,板塊內股票普漲,科濟藥業漲近12%、康希諾生物漲超10%、君實生物回彈近7%;
大型科技股普升,多股漲超7%。光大證券近期發表報告稱,仍然看好港股未來修復空間,該文推薦下的快手漲超7%;
互聯網醫療板塊漲超7%。平安好醫生漲7.17%、阿裏健康漲7.32%、京東健康漲7.09%。
熱門股
小鵬汽車跌近6%,據悉,小鵬汽車近期領投的一徑科技完成C輪融資,該公司爲車規級MEMS激光雷達解決方案提供商;
植髮第一股---雍禾醫療跌超5%、或因與上週超額配股權行權有關.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.